Cover Image

Neuropsychiatric systemic lupus erythematosus: where are we now?

When dealing with neuropsychiatric Systemic Lupus Erythematosus (NPSLE) there are still many controversial topics. In 1999 the American College of Rheumatology gave classification criteria for 19 clinical syndromes. However major problems are still related to low specificity of some of them such as...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. Padovan (Author), G. Castellino (Author), N. Rizzo (Author), M. Govoni (Author), F. Trotta (Author)
Format:	Book
Published:	PAGEPress Publications, 2011-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The evaluation of neuropsychiatric lupus erythematosus by functional neuroimaging. Preliminary results
by: M. Padovan, et al.
Published: (2004)

Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre
by: F. De Leonardis, et al.
Published: (2012)

Neuropsychiatric Lupus Erythematosus
by: A. Palma Modoni, et al.
Published: (2011)

Comprehensive Insights into Neuropsychiatric Systemic Lupus Erythematosus
by: Monika Turek, et al.
Published: (2024)

Diabetes insipidus in neuropsychiatric-systemic lupus erythematosus patient
by: Y Pangestu, et al.
Published: (2018)

Electroencephalography in systemic lupus erythematosus patients with neuropsychiatric manifestations
by: Howaida E. Mansour, et al.
Published: (2020)

Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE)
by: Valentina Natoli, et al.
Published: (2023)

Where are we now and where are we headed?
by: Ewan A. Langan
Published: (2023)

Animal models of neuropsychiatric systemic lupus erythematosus: deciphering the complexity and guiding therapeutic development
by: Baruh Polis, et al.
Published: (2024)

Diagnostic performance of aPS/PT antibodies in neuropsychiatric lupus and cardiovascular complications of systemic lupus erythematosus
by: Giuseppe A. Ramirez, et al.
Published: (2020)

Cannabinoids in Periodontology: Where Are We Now?
by: Yésica Carmona Rendón, et al.
Published: (2023)

Neonatal sepsis biomarkers: where are we now?
by: Gilfillan M, et al.
Published: (2019)

Osteochondral techniques: where are we now?
by: Giovanna Medina, et al.
Published: (2023)

Idiopathic Intracranial Hypertension: Neuropsychiatric Systemic Lupus Erythematosus or Gonadotropinreleasing hormone agonist side effect?
by: Ong Ping Seung, et al.
Published: (2017)

Resistant Hypertension: Where are We Now and Where Do We Go from Here?
by: Pathan MK, et al.
Published: (2020)

Synergies for Better Learning - Where Are We Now?
by: Morten Søby
Published: (2013)

Born too Early, Where are We Now?
by: Hermanto T Joewono
Published: (2018)

Fat and bone in children - where are we now?
by: Paul Dimitri
Published: (2018)

Neuropsychiatric Manifestation Screening among Systemic Lupus Erythematosus Patients in Hasan Sadikin General Hospital Bandung
by: Septian Dwi Putra, et al.
Published: (2018)

Editorial: Neonatal ECMO in 2019: Where Are We Now? Where Next?
by: Giacomo Cavallaro, et al.
Published: (2022)

Noninvasive prenatal testing of aneuploidies: where are we now?
by: Aleksandra Jezela-Stanek, et al.
Published: (2014)

Anticytokine therapy for periodontal diseases: Where are we now?
by: Waykole Yogesh, et al.
Published: (2009)

Medical-Dental Integration in Medicare: Where are We Now?
by: Lisa Simon, et al.
Published: (2023)

Artemisinin resistance and malaria elimination: Where are we now?
by: Borimas Hanboonkunupakarn, et al.
Published: (2022)

Editorial: Antipsychotics of New Generation: Where Are We now?
by: Tatiana V. Lipina, et al.
Published: (2021)

Neuropsychiatric lupus in children
by: Imundo L, et al.
Published: (2011)

A Hundred Years of Diagnosing Superficial Fungal Infections: Where Do We Come From, Where Are We Now and Where Would We Like To Go?
by: Yvonne Gräser, et al.
Published: (2020)

Neuropsychiatric Outcome of Children Born to Women With Systemic Lupus Erythematosus and Exposed in Utero to Azathioprine: A Case-Control Study
by: Maria-Grazia Lazzaroni, et al.
Published: (2020)

Autoantibodies to NR2A Peptide of the Glutamate/NMDA Receptor in Patients with Seizure Disorders in Neuropsychiatric Systemic Lupus Erythematosus
by: Yan Yang, et al.
Published: (2017)

Where Are We Now with the Implementation of the Talent Development Framework for Gifted Students and Where Do We Go in the Future?
by: Paula Olszewski-Kubilius
Published: (2024)

Peripheral Markers of Immune Response in Major Psychiatric Disorders: Where Are We Now and Where Do We Want to Be?
Published: (2019)

Adjuvant treatment for high risk melanoma. Where are we now?
by: Anand Sharma, et al.
Published: (2011)

Adjuvant treatment for high risk melanoma. Where are we now?
by: Anand Sharma, et al.
Published: (2011)

Cyberbullying: Where Are We Now? A Cross-National Understanding
by: Conor Mc Guckin (Ed.)
Published: (2017)

Medical education and post pandemic challenges: where are we now?
by: Valeria Vásquez Estrada, et al.
Published: (2023)

Human Papillomavirus Vaccine for Cervical Cancer: Where are we Now?
by: Horng-Jyh Tsai, MD, FACOG
Published: (2005)

Human Papillomavirus Vaccine for Cervical Cancer: Where Are We Now?
by: Wen-Fang Cheng
Published: (2005)

Oral microbiome and peri-implant diseases: where are we now?
by: Pokrowiecki R, et al.
Published: (2017)

International workshop on "professionalism in the practice of medicine- where are we now?"
by: Ora Paltiel, et al.
Published: (2017)

Application of Artificial Intelligence in Capsule Endoscopy: Where Are We Now?
by: Youngbae Hwang, et al.
Published: (2018)